Cargando…

Effect of JAK1/2 inhibition on High-Output Heart Failure Associated With Myeloproliferative Disease

Detalles Bibliográficos
Autores principales: Fujii, Yuki, Takei, Makoto, Hayashi, Risa, Yagi, Ryuichiro, Kawano, Megumi, Endo, Ayaka, Suzuki, Kenji, Hirata, Naoki, Hasegawa, Tasuku, Takahashi, Toshiyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8352270/
https://www.ncbi.nlm.nih.gov/pubmed/34396239
http://dx.doi.org/10.1016/j.jaccao.2020.02.018
_version_ 1783736144579526656
author Fujii, Yuki
Takei, Makoto
Hayashi, Risa
Yagi, Ryuichiro
Kawano, Megumi
Endo, Ayaka
Suzuki, Kenji
Hirata, Naoki
Hasegawa, Tasuku
Takahashi, Toshiyuki
author_facet Fujii, Yuki
Takei, Makoto
Hayashi, Risa
Yagi, Ryuichiro
Kawano, Megumi
Endo, Ayaka
Suzuki, Kenji
Hirata, Naoki
Hasegawa, Tasuku
Takahashi, Toshiyuki
author_sort Fujii, Yuki
collection PubMed
description
format Online
Article
Text
id pubmed-8352270
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-83522702021-08-13 Effect of JAK1/2 inhibition on High-Output Heart Failure Associated With Myeloproliferative Disease Fujii, Yuki Takei, Makoto Hayashi, Risa Yagi, Ryuichiro Kawano, Megumi Endo, Ayaka Suzuki, Kenji Hirata, Naoki Hasegawa, Tasuku Takahashi, Toshiyuki JACC CardioOncol Clinical Case Challenges Elsevier 2020-06-16 /pmc/articles/PMC8352270/ /pubmed/34396239 http://dx.doi.org/10.1016/j.jaccao.2020.02.018 Text en © 2020 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Clinical Case Challenges
Fujii, Yuki
Takei, Makoto
Hayashi, Risa
Yagi, Ryuichiro
Kawano, Megumi
Endo, Ayaka
Suzuki, Kenji
Hirata, Naoki
Hasegawa, Tasuku
Takahashi, Toshiyuki
Effect of JAK1/2 inhibition on High-Output Heart Failure Associated With Myeloproliferative Disease
title Effect of JAK1/2 inhibition on High-Output Heart Failure Associated With Myeloproliferative Disease
title_full Effect of JAK1/2 inhibition on High-Output Heart Failure Associated With Myeloproliferative Disease
title_fullStr Effect of JAK1/2 inhibition on High-Output Heart Failure Associated With Myeloproliferative Disease
title_full_unstemmed Effect of JAK1/2 inhibition on High-Output Heart Failure Associated With Myeloproliferative Disease
title_short Effect of JAK1/2 inhibition on High-Output Heart Failure Associated With Myeloproliferative Disease
title_sort effect of jak1/2 inhibition on high-output heart failure associated with myeloproliferative disease
topic Clinical Case Challenges
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8352270/
https://www.ncbi.nlm.nih.gov/pubmed/34396239
http://dx.doi.org/10.1016/j.jaccao.2020.02.018
work_keys_str_mv AT fujiiyuki effectofjak12inhibitiononhighoutputheartfailureassociatedwithmyeloproliferativedisease
AT takeimakoto effectofjak12inhibitiononhighoutputheartfailureassociatedwithmyeloproliferativedisease
AT hayashirisa effectofjak12inhibitiononhighoutputheartfailureassociatedwithmyeloproliferativedisease
AT yagiryuichiro effectofjak12inhibitiononhighoutputheartfailureassociatedwithmyeloproliferativedisease
AT kawanomegumi effectofjak12inhibitiononhighoutputheartfailureassociatedwithmyeloproliferativedisease
AT endoayaka effectofjak12inhibitiononhighoutputheartfailureassociatedwithmyeloproliferativedisease
AT suzukikenji effectofjak12inhibitiononhighoutputheartfailureassociatedwithmyeloproliferativedisease
AT hiratanaoki effectofjak12inhibitiononhighoutputheartfailureassociatedwithmyeloproliferativedisease
AT hasegawatasuku effectofjak12inhibitiononhighoutputheartfailureassociatedwithmyeloproliferativedisease
AT takahashitoshiyuki effectofjak12inhibitiononhighoutputheartfailureassociatedwithmyeloproliferativedisease